Back to Authors

Bakri, Sophie J.

https://orcid.org/0000-0002-0887-3194

A5006761392 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 36

Ultrasound Biomicroscopy in Pseudophakic Patients with Unexplained Recurrent Hyphema or Vitreous Hemorrhage

Seminars in Ophthalmology | December 18, 2016 | Volume: 33 | Issue: 2 | Pages: 260-264

10.1080/08820538.2016.1228984 | PMID 27960582

Pharmacogenomics of Response to Anti-VEGF Therapy in Exudative Age-Related Macular Degeneration

Ophthalmic Disease Mechanisms and Drug Discovery | August 10, 2016 | Volume: No volume available | Issue: No issue available | Pages: 63-95

10.1142/9789814663076_0004

Representation of Women With Industry Ties in Ophthalmology

JAMA Ophthalmology | April 21, 2016 | Volume: 134 | Issue: 6 | Pages: 636

10.1001/jamaophthalmol.2016.0552 | PMID 27101532

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema

JAMA Ophthalmology | October 29, 2015 | Volume: 134 | Issue: 1 | Pages: 95

10.1001/jamaophthalmol.2015.4110 | PMID 26512939

Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up

Seminars in Ophthalmology | April 30, 2015 | Volume: 31 | Issue: 6 | Pages: 542-547

10.3109/08820538.2015.1009555 | PMID 25927243

Silicone Oil Emulsification at the Fovea as a Reversible Cause of Vision Loss

JAMA Ophthalmology | January 15, 2015 | Volume: 133 | Issue: 4 | Pages: 484

10.1001/jamaophthalmol.2014.5505 | PMID 25590568

Optical Coherence Tomography in Retinal Arterial Occlusions: Case Series and Review of the Literature

Seminars in Ophthalmology | September 27, 2013 | Volume: 30 | Issue: 1 | Pages: 74-79

10.3109/08820538.2013.821507 | PMID 24074452

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Due to Sorsby Macular Dystrophy

Journal of Ocular Pharmacology and Therapeutics | April 12, 2013 | Volume: 29 | Issue: 4 | Pages: 444-447

10.1089/jop.2011.0206 | PMID 23581613

Evolution of Vitreomacular Traction Following the Use of the Dexamethasone Intravitreal Implant (Ozurdex) in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion

Journal of Ocular Pharmacology and Therapeutics | April 26, 2012 | Volume: 28 | Issue: 5 | Pages: 547-549

10.1089/jop.2011.0184 | PMID 22537269

Abstract Purpose: To report a case of worsening of vitreomacular traction (VMT) after the dexamethasone intravitreal implant (Ozurdex; Allergan, Inc., Irvine, CA) for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). Case: A 71-year-old man who presented with macular edema secondary to CRVO was treated by intravitreal injections of bevacizumab followed by Ozurdex. Results: VMT developed during the course of treatment and became more evident when macular edema resolved after treatment with Ozurdex. Conclusion: VMT may become apparent and worsen after resolution of macular edema treated with intravitreal Ozurdex.
Administration of Repeat Intravitreal Anti-VEGF Drugs by Retina Specialists in an Injection-only Clinic for Patients with Exudative AMD: Patient Acceptance and Safety

Seminars in Ophthalmology | November 1, 2011 | Volume: 26 | Issue: 6 | Pages: 380-386

10.3109/08820538.2011.622337 | PMID 22044336